Skip to content

Toggle main navigation

U.S. Anesthesia Partners Launches USAP4USAP, a 501(c)3 Nonprofit Dedicated to Helping USAP Team Members in Need

Published on June 21, 2024

U.S. Anesthesia Partners Launches USAP4USAP, a 501(c)3 Nonprofit Dedicated to Helping USAP Team Members in Need Jodi_Lewis Fri, 06/21/2024 - 09:41

Read more about U.S. Anesthesia Partners Launches USAP4USAP, a 501(c)3 Nonprofit Dedicated to Helping USAP Team Members in Need

Continue reading on website

Other news

Abzena & Argonaut Partner to Offer Accelerated End-to-End Drug Development Support

Biopharma gains a seamless transition from drug discovery through drug product manufacturingSan Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving the biopharmaceutical and diagnostics industries, announced a strategic

The Urgent Need for Reliable Cell Models in ALS Drug Development

Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative disease that has eluded effective treatment for over a century. Recent high-profile failures in ALS drug trials highlight a critical gap in the drug development process: the need for more reliable cell models to better predict clinical outcomes.